Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Medicine’s Missing Half: How Withholding Clinical Trials Degrades the Evidence Base

March 01, 2013

Medicine’s Missing Half: How Withholding Clinical Trials Degrades the Evidence Base
Dr. Ben Goldacre, author of Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, discusses the pervasive bias in reporting clinical trials of medications.

He calls for all trials to be registered and for all trial results to be reported. Otherwise, he says, doctors, researchers, and patients are prevented from making discerning decisions about treatments and the field of evidence-based medicine is pointlessly hobbled. For more, see alltrials.net.